3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
34
Lung Neoplasms
19
Small Cell Lung Carcinoma
16
Mesothelioma, Malignant
7
Adenocarcinoma of Lung
7
Ovarian Neoplasms
3
Stomach Neoplasms
2
Sarcoma
2
Recurrence
2
Non-squamous Non-small Cell Lung Cancer
2
NSCLC
2
Brain Neoplasms
2
Wilms Tumor
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solitary Fibrous Tumor, Pleural
1
Small Cell Lung Cancer Extensive Stage
1
SCLC
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Penile Neoplasms
1
Pelvic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Non-squamous NSCLC
1
Non-small Cell Lung Cancer Metastatic
1
Mesothelioma
1
Liposarcoma
1
Gallbladder Neoplasms
1
Interventions
pembrolizumab
4
Pemetrexed
4
Carboplatin
4
Gemcitabine
3
Bevacizumab
3
tusamitamab ravtansine
2
Vinorelbine
2
Ramucirumab
2
Erlotinib Hydrochloride
2
Docetaxel
2
1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine
2
vistusertib
1
vandetanib
1
telomerase reverse transcriptase p572Y, human
1
spartalizumab
1
sotorasib
1
sintilimab
1
olaparib
1
necitumumab
1
icotinib
1
durvalumab
1
dacomitinib
1
capivasertib
1
aumolertinib
1
Radiosurgery
1
Platinum
1
Paclitaxel
1
MLN 8237
1
LY3023414
1
Injections
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Non-small Cell Lung Cancer Metastatic
×
Platinum
×
Thoracic
×
Clear all
NCT05407155
2026-04-23
BETTER
Fudan University
Phase NA
Active not recruiting
56 enrolled